DE3788899T2 - Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons. - Google Patents

Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons.

Info

Publication number
DE3788899T2
DE3788899T2 DE87304642T DE3788899T DE3788899T2 DE 3788899 T2 DE3788899 T2 DE 3788899T2 DE 87304642 T DE87304642 T DE 87304642T DE 3788899 T DE3788899 T DE 3788899T DE 3788899 T2 DE3788899 T2 DE 3788899T2
Authority
DE
Germany
Prior art keywords
cell carcinoma
recombinant human
basal cell
human alpha
alpha interferons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87304642T
Other languages
English (en)
Other versions
DE3788899D1 (de
Inventor
Daniel Jay Tanner
Edwin Arnold Peets
Kenneth Albert Smiles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE3788899D1 publication Critical patent/DE3788899D1/de
Application granted granted Critical
Publication of DE3788899T2 publication Critical patent/DE3788899T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE87304642T 1986-05-27 1987-05-26 Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons. Expired - Fee Related DE3788899T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86664486A 1986-05-27 1986-05-27

Publications (2)

Publication Number Publication Date
DE3788899D1 DE3788899D1 (de) 1994-03-10
DE3788899T2 true DE3788899T2 (de) 1994-05-05

Family

ID=25348060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87304642T Expired - Fee Related DE3788899T2 (de) 1986-05-27 1987-05-26 Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons.

Country Status (13)

Country Link
EP (1) EP0248583B1 (de)
JP (1) JPS62289526A (de)
KR (1) KR870010871A (de)
AT (1) ATE100717T1 (de)
AU (1) AU601741B2 (de)
CA (1) CA1295243C (de)
DE (1) DE3788899T2 (de)
DK (1) DK264787A (de)
ES (1) ES2061496T3 (de)
IE (1) IE62318B1 (de)
IL (1) IL82654A0 (de)
PH (1) PH26198A (de)
ZA (1) ZA873743B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (de) * 1987-02-09 1989-03-08 Schering Corporation Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
ATE92333T1 (de) * 1988-12-01 1993-08-15 Schering Corp Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
AU9132091A (en) * 1990-12-21 1992-07-22 Schering Corporation Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
US20200038487A1 (en) 2017-03-31 2020-02-06 Accanis Biotech F&E Gmbh & Co Kg Prevention and treatment of non-melanoma skin cancer (nmsc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU1152983A (en) * 1982-01-15 1983-07-28 Cetus Corporation Interferon alpha 74
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
AU1153083A (en) * 1982-01-15 1983-07-28 Cetus Corporation Interferon-alpha 54
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex

Also Published As

Publication number Publication date
EP0248583B1 (de) 1994-01-26
DE3788899D1 (de) 1994-03-10
ES2061496T3 (es) 1994-12-16
CA1295243C (en) 1992-02-04
AU7336687A (en) 1987-12-03
DK264787D0 (da) 1987-05-25
DK264787A (da) 1987-11-28
IL82654A0 (en) 1987-11-30
JPS62289526A (ja) 1987-12-16
EP0248583A2 (de) 1987-12-09
ATE100717T1 (de) 1994-02-15
PH26198A (en) 1992-03-18
EP0248583A3 (en) 1989-10-18
IE871358L (en) 1987-11-27
ZA873743B (en) 1987-11-25
AU601741B2 (en) 1990-09-20
IE62318B1 (en) 1995-01-25
KR870010871A (ko) 1987-12-18

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
BG60324B2 (en) New somatotropines
ATE100717T1 (de) Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
DE68908119D1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE69104619T2 (de) Verwendungsmethoden von humanem Gammainterferon 4-134.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
KR900012628A (ko) 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
KR880001300A (ko) 리트로바이러스 감염의 예방 및 치료를 위한 방법 및 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee